IPO market re-opens, sort of, as Calyxt raises $56M in NASDAQ offering
In Minnesota, Calyxt, the gene editing agriculture company, raised $56M and priced its NASDAQ initial public offering of 7 million shares at $8.00. The number of shares in the offering was sweetened to 7 million this week, from the original estimate of 6.06 million — and the price was substantially lower than the expected $15.00-$18.00 […]












